Table 3.
Graft survival | Hazard ratio (95% CI) | P-value |
---|---|---|
Duration of brain death period (hours) | 0.933 (0.882–0.987) | .015 |
Donor gender (Female/Male) | 1.247 (0.870–1.789) | .230 |
Donor age (years) | 1.035 (1.012–1.058) | .003 |
Donor body mass index (kg/m2) | 0.965 (0.923–1.009) | .120 |
Expanded criteria donor | 1.203 (0.699–2.073) | .505 |
Donor history of hypertension | 1.164 (0.781–1.733) | .456 |
Donor hypotensive period(s) | 0.921 (0.640–1.325) | .657 |
Donor history of diabetes mellitus | 5.415 (1.608–18.237) | .006 |
Donor history of cardiac arrest | 1.213 (0.802–1.835) | .360 |
Donor use of inotropic medication | 1.886 (0.994–3.578) | .088 |
Donor cause of death: stroke | 0.611 (0.398–0.937) | .024 |
Donor cause of death: trauma | 0.812 (0.481–1.370) | .435 |
Donor lowest creatinine (μmol/L) | 1.001 (1.000–1.001) | .013 |
Recipient gender (Female/Male) | 1.088 (0.755–1.567) | .651 |
Recipient age (years) | 0.973 (0.959–0.987) | .000 |
Recipient body mass index (kg/m2) | 1.008 (0.966–1.051) | .726 |
Recipient dialysis duration (years) | 0.996 (0.903–1.099) | .939 |
Cold ischemia time (hours) | 1.015 (0.987–1.045) | .286 |
Anastomosis time (minutes) | 0.994 (0.980–1.007) | .336 |
Number of HLA mismatches | 0.927 (0.808–1.064) | .283 |
Delayed graft function | 2.279 (1.541–3.369) | .000 |
Acute graft rejection within 1 year | 4.122 (2.541–6.686) | .000 |
HLA – human leukocyte antigen.